Pioneering Cancer Care – The landscape of cancer care is constantly improving. However, the path from early detection to diagnosis and treatment continues to become increasingly complex.
A cancer diagnosis is a life-changing event, and disparities based on race, ethnicity, and socioeconomic status lead to unmet needs along the way. These inconsistencies span the continuum of cancer care and can be attributed to inequitable access to and engagement with health services.
Pioneering Cancer Care
Principal Investigators of the GINO (Global Implementation of Navigation in Oncology) research project, Prof Raymond Chen and Dr Fiona Crawford-Williams from the Future Care Institute, together with Dr Margaret Fitch, Head of Oncology Nursing at the Odette Cancer Center (Sunnybrook Health Science Centre, Toronto , Canada) are working alongside Caring Futures Institute researchers Dr. Imogen Ramsey and Dr. Carla Thamm, in partnership with the Multinational Association for Supportive Cancer Care (MASCC). Generously funded by Novartis. This project aims to eliminate barriers and promote equitable cancer care, globally.
Advanced In Cancer Treatment: Pioneering Passage Towards Hope And Healing By Narayanacancercentre
“There is growing recognition that managing the health care system as a person with cancer or an informal caregiver can be an overwhelming experience… This challenge is compounded by structural, cultural and personal barriers, including limited knowledge, financial constraints, lack of insurance, geographic distance from care providers and lack of basic cancer care resources.”
While current pathways offer guidance for cancer patients, if they are to receive the best possible care, additional help and ongoing support is needed to navigate complex healthcare systems.
To address these challenges, patient navigation has been identified as a strategic solution. This approach addresses both individual and systemic barriers, working to improve the care experience. This method improves access to timely treatments, simplifies appointments for those who are most vulnerable. Patient navigation acts as a valuable bridge, ensuring equitable and timely care for patients in need.
“The project aims to ensure that quality, evidence-based patient navigation interventions are implemented in practice to reduce barriers to accessing cancer care and improve patient outcomes.” Dr. Crawford-Williams says.
Clinical Excellence, Pioneering Research
The GINO project builds on a recent study of patient navigation through the cancer continuum by the Caring Futures Institute cancer survivorship team, led by Professor Raymond Chan, Dr Nicholas Hart, Dr Fiona Crawford-Williams and Professor Julie Ratcliffe, in collaboration with Cancer Australia. . This recent study, published in CA: A Cancer Journal for Clinicians, not only confirmed the effectiveness and cost-effectiveness of cancer navigation programs, but also identified gaps in the scientific literature that require further research.
The GINO project, which started in July 2023, is expected to last three years and has three phases. The first phase is the development of a framework for navigating cancer patients through a Delphi consensus study. Once the framework is developed, a team of experts from MASCC will be tasked with establishing a global position statement for patient navigation in cancer.
During the second phase, the expert group will develop a core set of quality and effectiveness indicators and then test them in existing cancer navigation programs. During the third phase, the group will create customizable implementation guidelines suitable for different healthcare facilities. In addition, a global community of practice led by expert working group and project team members will be established.
“A community of practice will be launched to compare and share patient navigation resources and tools, to monitor and assist in local adaptation of patient navigation programs and to assist in sustainable implementation.” Dr. Crawford-Williams says.
The Future Of Cancer Treatment: Exploring Triox Nano’s Pioneering Approach
“This initiative works closely with global experts to translate research into practice in different countries.” It uses existing programs worldwide to adapt patient navigation to local contexts.
“Furthermore, the global community of practice will ensure that quality evidence is available and that a plan to support sustainability beyond the project period will be explored and co-developed with its members.”
The GINO research project acts as a catalyst for change that nurtures a global community dedicated to building better lives, better communities, better care and better systems. To protect patients, visitors and staff from influenza, COVID-19, RSV and other viruses this winter, we may change the masking requirements and guidelines for visitors to our hospitals and clinics. Learn more.
May not work properly with this and other websites. We recommend upgrading to the latest Microsoft browser.
Pioneering Cancer Vaccine Trials Could Start In Uk By September
Learning that you may have cancer can be overwhelming – for you and your loved ones. We know you have questions about what lies ahead and how best to move forward. At , we offer a combination of expertise, treatment options and compassionate support that is personalized to meet your goals. With our widespread network of conveniently located facilities throughout the Pacific Northwest, the care you need during every stage of this experience — from diagnosis to treatment to survivorship — is always at your fingertips.
Our team of cancer specialists includes board-certified physicians who have completed additional training in areas such as medical oncology and cancer surgery. They work in concert with other professionals, such as social workers and nurse navigators, to ease your journey through cancer treatment.
At , you will have access to the most advanced cancer treatments available. We use the latest radiation therapy technologies and radiosurgery systems that deliver high doses of radiation with superior accuracy. We also offer innovative approaches such as precision medicine, which tailors treatment to the molecular characteristics of a person’s particular cancer. Learn more about available treatments:
Has been a trusted partner in cancer research since 1983. This means you have local access to promising new care options that are usually only available at large, university hospitals.
Ncis Celebrates 15 Years Of Pioneering Cancer Care With Family Carnival
Through the Institute for Research and Innovation, we offer more than 50 cancer clinical trials at any given time, testing different treatments. Learn more about cancer research at .Healthcare company Varian is innovating new technologies to help healthcare providers and cancer patients plan and manage their treatment
Kevin Lo, senior managing director for Varian’s Southeast Asia and Korea region, has been with Varian for nearly nine years. He spent the last 25 years of his career in healthcare and 15 years in radiation oncology.
“I’ve seen enough cancer patients,” Lo says of his time in this challenging but exciting career. “I’ve also seen both my parents get cancer – now they’re cancer survivors. But my mother-in-law passed away from leukemia. That’s why cancer is always on my mind, not only professionally, but also in my personal life.
“I think at Varian we share a very important passion related to creating or achieving a world without the fear of cancer.” It is truly something in our minds and in our hearts. From the top down to the very core staff, we are working on that mission.”
Dr. William Tran Honored With The 2023 Edmond Odette Prize For Pioneering Ai Innovations In Cancer Care
Varian, a Siemens Healthineers company, wants to create a world without the fear of cancer. Founded in Palo Alto, California, USA, Varian has been developing technology solutions since 1948 and has since expanded worldwide. Lo moved to Varian because of his experience as a radiation oncologist and his interest in new technologies.
“I love new technology. My passion is how we transform these technologies so that they are commercialized and can be used clinically,” says Lo.
“At Varian, we bring new technologies to the region. We want to bring in connected data, technologies, workflows and the like to streamline operations in oncology.
“When we talk about personalized treatment, it means how we use data, artificial intelligence and technologies,” explains Lo. “During the cancer, even for the same patient, they will have different stages. We are adapting the way we treat cancer. We connect different doctors in an environment where they can talk to each other through a multidisciplinary cancer care board.
Ccil Planning Grant Powers Up Pioneering Glioblastoma Research
“They’re pretty impressed, because a lot of other companies may not be working with the patient at all, may not be working with the family,” Lo said. “We collaborate with many societies, such as the Hong Kong Cancer Society and other patient societies throughout Southeast Asia. We provide them with the necessary information and education to give them more knowledge about the technologies we use and more information about new ways to treat cancer.”
Improving access to care is a key indicator of success for Varian. In high-income countries, between 50-60% of cancer patients will typically receive radiation therapy as part of their treatment, but less than 10% actually receive it in low- to middle-income countries. Varian wants to help expand access to care in Southeast Asia.
“We want to inspire clinicians across the region with meaningful innovation that is affordable, accessible and simplified.” They can treat more patients with fewer challenges.”
“In 2007 In 2008, we founded the Varian Medical Systems Foundation, which guides our philanthropy and charitable giving. We work a lot with non-profit organizations and non-governmental organizations, making grants, donations and gifts to non-profit organizations that offer information and services focused on cancer prevention, detection and treatment.”
International Journal Of Cancer Care And Delivery
“In our offices in Singapore and Malaysia, we also participate in raising money for cancer patients. We participated in Pink October in Malaysia to raise awareness about breast cancer. We were honored to work with the first lady there.”
The foundation also funds ASRT Education and
Pioneering poles, pioneering, urban pioneering, pioneering projects, pioneering services, pioneering leadership, pioneering advertising, pioneering care, pioneering woman, pioneering costs, pioneering care centre, pioneering healthcare
